These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 19671913)

  • 1. Aspirin as adjuvant therapy for colorectal cancer: a promising new twist for an old drug.
    Neugut AI
    JAMA; 2009 Aug; 302(6):688-9. PubMed ID: 19671913
    [No Abstract]   [Full Text] [Related]  

  • 2. Aspirin use and survival after diagnosis of colorectal cancer.
    Chan AT; Ogino S; Fuchs CS
    JAMA; 2009 Aug; 302(6):649-58. PubMed ID: 19671906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aspirin, the new targeted therapy in colorectal cancer.
    Fuchs CS
    Clin Adv Hematol Oncol; 2014 Mar; 12(3):186-9. PubMed ID: 24927268
    [No Abstract]   [Full Text] [Related]  

  • 4. [Adjuvant therapeutic procedures in colorectal cancer: indications and possibilities].
    Porschen R; Bermann A
    Z Gastroenterol; 1993 Nov; 31 Suppl 5():35-8. PubMed ID: 8197798
    [No Abstract]   [Full Text] [Related]  

  • 5. [Pro and contra adjuvant chemotherapy in colorectal carcinoma].
    Mezger J; Glasmacher A
    Med Klin (Munich); 1996 Sep; 91(9):609-11. PubMed ID: 8984322
    [No Abstract]   [Full Text] [Related]  

  • 6. [Current aspects of adjuvant and palliative chemotherapy in colorectal carcinoma].
    Bokemeyer C; Hartmann JT; Kanz L
    Praxis (Bern 1994); 1997 Sep; 86(39):1510-6. PubMed ID: 9411671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aspirin, COX-2, and the risk of colorectal cancer.
    Benelli R
    N Engl J Med; 2007 Aug; 357(8):824-5; author reply 824-5. PubMed ID: 17715417
    [No Abstract]   [Full Text] [Related]  

  • 8. [Drug therapy of colorectal carcinoma].
    Ulrich-Pur H; Jech B; Scheithauer W; Kornek GV; Huber H
    Wien Klin Wochenschr; 2002 Jun; 114(10-11):368-76. PubMed ID: 12708089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aspirin, COX-2, and the risk of colorectal cancer.
    Murashige N; Kami M; Ikeda M
    N Engl J Med; 2007 Aug; 357(8):824-5; author reply 824-5. PubMed ID: 17717859
    [No Abstract]   [Full Text] [Related]  

  • 10. Surrogate endpoints in assessment of new drugs in colorectal cancer.
    Kelsen DP
    Lancet; 2000 Jul; 356(9227):353-4. PubMed ID: 10972363
    [No Abstract]   [Full Text] [Related]  

  • 11. Adjuvant chemotherapy for stage II and III colorectal cancer.
    Benson AB
    Clin Adv Hematol Oncol; 2011 Aug; 9(8):616-8. PubMed ID: 22236990
    [No Abstract]   [Full Text] [Related]  

  • 12. New possibilities in chemotherapy for colorectal cancer.
    Bekradda M; Cvitkovic E
    Ann Oncol; 1999; 10 Suppl 6():105-11. PubMed ID: 10676561
    [No Abstract]   [Full Text] [Related]  

  • 13. Adjuvant chemotherapy for colorectal cancer.
    Kerr DJ; Gray R
    Br J Hosp Med; 1996 Mar 6-19; 55(5):259-62. PubMed ID: 8777517
    [No Abstract]   [Full Text] [Related]  

  • 14. [Chemotherapy in colorectal carcinoma].
    Schmiegel W; Petrasch S
    Internist (Berl); 1994 Dec; 35(12):1086-94. PubMed ID: 7533749
    [No Abstract]   [Full Text] [Related]  

  • 15. Cyclooxygenase-2 expression is a prognostic biomarker for non-small cell lung cancer patients treated with adjuvant platinum-based chemotherapy.
    Shimizu K; Yukawa T; Okita R; Saisho S; Maeda A; Nojima Y; Nakata M
    World J Surg Oncol; 2015 Feb; 13():21. PubMed ID: 25888998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An anticancer drug sensitivity test to determine the effectiveness of UFT as postoperative adjuvant chemotherapy for patients with stage III colorectal cancer.
    Isogai A; Nagaya M; Matsuoka H; Watanabe T; Tsukikawa S; Kubota S
    Surgery; 2007 Nov; 142(5):741-8. PubMed ID: 17981195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Chemotherapy and radiochemotherapy of colorectal cancers: adjuvant and palliative therapeutic procedures].
    Porschen R; Bermann A
    Leber Magen Darm; 1994 Jul; 24(4):164-9. PubMed ID: 7523820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cyclooxygenase-2-expression in bladder cancer: tumor-biological and clinical implications].
    Wülfing C; Eltze E; Von Struensee D; Wülfing P; Bode ME; Bettendorf O; Piechota H; Hertle L
    Aktuelle Urol; 2004 Aug; 35(4):331-8. PubMed ID: 15459875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COX-2 expression in adenoma: an imperfect marker for chemoprevention.
    Chan AT
    Gut; 2010 May; 59(5):568-9. PubMed ID: 20427388
    [No Abstract]   [Full Text] [Related]  

  • 20. Factors predicting the response to oral fluoropyrimidine drugs: a phase II trial on the individualization of postoperative adjuvant chemotherapy using oral fluorinated pyrimidines in stage III colorectal cancer treated by curative resection (ACT-01 Study).
    Mori T; Ohue M; Takii Y; Hashizume T; Kato T; Kotake K; Sato T; Tango T
    Oncol Rep; 2013 Feb; 29(2):437-44. PubMed ID: 23232805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.